Understand the R&D position
We review the company, R&D activity, expenditure profile, records and expected claim timing, including information prepared with your advisers.
SME Capital Partners is developing business-purpose facilities from $100,000 to $1 million for eligible Australian R&D companies that want access to capital before the relevant company tax return is lodged or before an anticipated R&D tax benefit is received.
Innovative companies can spend heavily on people, prototypes, engineering, software, testing and experimentation during the year. The Australian R&D Tax Incentive may provide a tax offset for eligible companies and eligible activities, but the company generally incurs the R&D expenditure first and then completes the registration and tax-return process.
Our R&D funding product is designed to assess whether an approved business-purpose facility can bring some of that capital forward. An approved loan may be advanced before the relevant company tax return is lodged or before the anticipated tax benefit is received, depending on the quality of the R&D records, expected claim position, company financials and final facility structure.
Our team understands the commercial R&D funding workflow and the information typically required to assess a facility. We can explain our funding process and work alongside your accountant, registered tax agent or specialist R&D adviser. SME Capital Partners does not replace the company’s responsibility to self-assess R&D eligibility or obtain appropriate tax advice.
The R&D Tax Incentive is a government self-assessment program. Our role is separate: we assess commercial credit using the company’s expected R&D position as one part of the funding analysis.
We review the company, R&D activity, expenditure profile, records and expected claim timing, including information prepared with your advisers.
We consider the expected R&D benefit alongside financial performance, liquidity, existing liabilities, security and the proposed use of funds.
If the opportunity fits our criteria, proposed amount, pricing, term, repayment strategy, security and conditions are documented before acceptance.
Once documentation and conditions are satisfied, approved funds may be advanced ahead of the company tax return or anticipated tax benefit.
The anticipated R&D benefit is important, but it is not the only source of credit support. We assess the whole company and the evidence behind the proposed facility.
Whether the applicant appears to be an eligible R&D entity conducting activities that it and its advisers reasonably expect to satisfy the program requirements.
Contemporaneous records, R&D expenditure schedules, payroll and contractor information, project documentation and other evidence supporting the expected position.
Revenue, margins, cash flow, liabilities, tax position, existing finance, security and the company’s ability to meet the proposed facility if the R&D outcome is delayed or lower than expected.
Understanding that separation is important when assessing whether an early R&D facility is appropriate.
Companies are responsible for assessing whether they are eligible R&D entities, whether their activities qualify and whether expenditure is eligible. Registration of activities does not itself mean the activities are eligible.
Eligible activities must be registered with the Department of Industry, Science and Resources before the company claims the R&D tax offset in its company tax return. Registration generally must be applied for within 10 months after the end of the relevant income year.
An SME Capital Partners facility is separate commercial credit. Approval does not constitute an R&D finding, tax ruling, tax-agent opinion or guarantee that the Department or ATO will accept a claim.
Official program information: Australian Government R&D Tax Incentive overview.
Potentially. The product is designed so that, where the company and evidence satisfy our credit criteria, an approved facility may be advanced before the relevant company tax return is lodged or before the expected R&D tax benefit is received. Final timing depends on the particular assessment and documentation.
No. R&D registration does not itself confirm eligibility, and SME Capital Partners funding is independently subject to credit approval. Neither a loan approval nor website information guarantees the amount or timing of any R&D tax outcome.
Our experienced team can explain the funding process and the information we need. Your company remains responsible for its R&D self-assessment and tax return. We can work with your accountant, registered tax agent and R&D adviser, but applicants should use appropriately qualified advisers for tax and R&D claim advice.
The intended product range is $100,000 to $1 million. The approved amount may be lower and will depend on the expected R&D position, business financials, evidence, security, repayment strategy and final credit assessment.
The repayment mechanics will be set out in the relevant facility documents. The expected R&D benefit may form part of the proposed repayment strategy, but borrowers remain bound by the agreed facility terms.